NCT05324488 Diabetes Registry Graz for Biomarker Research
| NCT ID | NCT05324488 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Graz |
| Condition | Type1diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2015-10-21 |
| Primary Completion | 2035-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2015-10-21 with a primary completion date of 2035-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Diabetes registry for biomarker research Graz is a prospective cohort-study including subjects with type 1 and type 2 diabetes, rare types of diabetes, obesity and dyslipidemia, aiming to collect data, blood and urine samples of all subjects on an annual basis.
Eligibility Criteria
Inclusion Criteria: * 18 - 99 years * Informed consent has to be given in written form * At least one of the following diseases: * Type 1 diabetes * Type 2 diabetes * Type 3 diabetes * Maturity onset diabetes of young (MODY) * Late onset diabetes of the adult (LADA) * Adipositas (BMI \> 30kg/m2) * Lipid metabolism disorder Exclusion Criteria: * No written informed consent * No willingness to participate in this registry
Contact & Investigator
Caren Sourij, MD
✉ caren.sourij@medunigraz.atHarald Sourij, MD
PRINCIPAL INVESTIGATOR
Medical University of Graz
Frequently Asked Questions
Who can join the NCT05324488 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Type1diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05324488 currently recruiting?
Yes, NCT05324488 is actively recruiting participants. Contact the research team at caren.sourij@medunigraz.at for enrollment information.
Where is the NCT05324488 trial being conducted?
This trial is being conducted at Graz, Austria.
Who is sponsoring the NCT05324488 clinical trial?
NCT05324488 is sponsored by Medical University of Graz. The principal investigator is Harald Sourij, MD at Medical University of Graz. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.